Aug 18, 2026 07:01AM
Aug 18, 2026 07:00AM
Aug 3, 2026 07:00AM
Aug 3, 2026 07:00AM
Jun 22, 2026 09:00AM
Jun 22, 2026 09:00AM
Jun 17, 2026 09:00AM Genprex to Participate at BIO International Convention 2026
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
Apr 30, 2026 08:03AM
Apr 30, 2026 08:00AM
Apr 28, 2026 07:00AM GENPREX collaborators to present type 2 diabetes gene therapy data at May meeting
Apr 28, 2026 07:00AM
Apr 22, 2026 07:01AM
Apr 22, 2026 07:00AM
Apr 21, 2026 07:01AM
Apr 21, 2026 07:00AM
Apr 20, 2026 07:01AM
Apr 20, 2026 07:00AM Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Mar 18, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 10, 2026 07:00AM
Feb 23, 2026 08:02AM
Feb 23, 2026 08:00AM
Feb 10, 2026 08:00AM
Feb 10, 2026 08:00AM Genprex Announces IP Australia's Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
Jan 7, 2026 07:00AM
Jan 6, 2026 07:01AM
Jan 6, 2026 07:00AM
Nov 24, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 19, 2025 07:00AM
Nov 18, 2025 07:00AM Genprex receives US patent for cancer gene therapy combination through 2037
Nov 18, 2025 07:00AM
Nov 4, 2025 07:02AM
Nov 4, 2025 07:00AM
Oct 28, 2025 11:20AM
Oct 28, 2025 11:19AM
Oct 28, 2025 07:00AM
Oct 28, 2025 07:00AM Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets an
Oct 23, 2025 08:12AM
Oct 23, 2025 08:12AM
Oct 23, 2025 07:02AM
Oct 23, 2025 07:00AM
Oct 14, 2025 07:00AM
Sep 2, 2025 08:30AM
Aug 18, 2025 09:29AM Genprex receives patent allowances for Reqorsa cancer therapy combinations
Aug 18, 2025 09:29AM

330,175 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All